-+ 0.00%
-+ 0.00%
-+ 0.00%

AIM IMMUNOTECH INC: ADDITIONAL MEDIAN OVERALL SURVIVAL AND IMMUNE-RESPONSE DATA ON AMPLIGEN EXPECTED MID-YEAR 2027

Reuters·11/13/2026 13:30:01

Please log in to view news